A novel strategy for in vivo expansion of transplanted hepatocytes using preparative hepatic irradiation and FasL-induced hepatocellular apoptosis
- 1 February 2003
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 10 (4) , 304-313
- https://doi.org/10.1038/sj.gt.3301909
Abstract
A strategy for inducing preferential proliferation of the engrafted hepatocytes over host liver cells should markedly increase the benefit of hepatocyte transplantation for the treatment of liver diseases and ex vivo gene therapy. We hypothesized that preparative hepatic irradiation (HIR) to inhibit host hepatocellular regeneration in combination with the mitotic stimulus of host hepatocellular apoptosis should permit repopulation of the liver by transplanted cells. To test this hypothesis, congeneic normal rat hepatocytes were transplanted into UDP-glucuronosyltransferase (UGT1A1)-deficient jaundiced Gunn rats (a model of Crigler-Najjar syndrome type I), following HIR and adenovirus-mediated FasL gene transfer. Progressive repopulation of the liver by engrafted UGT1A1-proficient hepatocytes over 5 months was demonstrated by the appearance of UGT1A1 protein and enzyme activity in the liver, biliary bilirubin glucuronides secretion, and long-term normalization of serum bilirubin levels. This is the first demonstration of massive hepatic repopulation by transplanted cells by HIR and FasL-induced controlled apoptosis of host liver cells.Keywords
This publication has 31 references indexed in Scilit:
- Selective Repopulation of Normal Mouse Liver by Hepatocytes Transducedin Vivowith Recombinant Adeno-Associated VirusHuman Gene Therapy, 2001
- Human Hepatocyte Transplantation: Gene Therapy and More?Pediatrics, 1998
- Efficient Fas-ligand gene expression in rodent liver after intravenous injection of a recombinant adenovirus by the use of a Cre-mediated switching systemGene Therapy, 1998
- FasL induces Fas/Apo1-mediated apoptosis in human embryonic kidney 293 cells routinely used to generate E1-deleted adenoviral vectorsGene Therapy, 1998
- Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.The Journal of Experimental Medicine, 1995
- Purification and characterization of the Fas-ligand that induces apoptosis.The Journal of Experimental Medicine, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Lethal effect of the anti-Fas antibody in miceNature, 1993
- The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosisCell, 1991
- HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLSThe Journal of cell biology, 1969